Publications
Publications 4251 - 4275 de 33557
| Titre | DOI |
|---|---|
|
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised G. von Minckwitz; F. Puglisi; J. Cortes; E. Vrdoljak; N. Marschner; C. Zielinski; C. Villanueva; G. Romieu; I. Lang; E. Ciruelos; M. De laurentiis; C. Veyret; S. de Ducla; U. Freudensprung; S. Srock; J. Gligorov 2014 |
10.1016/S1470-2045(14)70439-5 |
|
Bevacizumab plus chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results T. Aparicio; O. Bouche; J. Taieb; E. Maillard; S. Kirscher; P.L. Etienne; R. Faroux; K. Akouz; E. Hajbi; C. Locher; Y. Rinaldi; T. Lecomte; S. Lavau-Denes; M. Baconnier; A. Oden-Gangloff; D. Genet; E. Paillaud; F. Retornaz; E. Francois; L. Bedenne; P.R.O.D.I.G.E.20 Investigators 2018 |
10.1093/annonc/mdx529 |
|
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR group A. de Gramont; J. Henriques; B. Baruch; T.W. Kim; M. Martinez-Villacampa; J. Gallego-Plazas; A. Cervantes; K. Shim; D.J. Jonker; V. Guerin-Meyer; L. Mineur; M. Banzi; A. Dewdney; S. Dejthevaporn; H.J. Bloemendal; A.D. Roth; P. Thompson; M. Moehler; A. Aguilar; T. Andre 2019 |
|
|
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR group A. de Gramont; J. Henriques; B. Baruch; T.W. Kim; M. Martinez-Villacampa; J. Gallego-Plazas; A. Cervantes; K. Shim; D.J. Jonker; V. Guerin-Meyer; L. Mineur; M. Banzi; A. Dewdney; S. Dejthevaporn; H.J. Bloemendal; A.D. Roth; P. Thompson; M. Moehler; A. Aguilar; T. Andre 2019 |
|
|
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial C. Tournigand; B. Chibaudel; B. Samson; W. Scheithauer; D. Vernerey; P. Mesange; G. Lledo; F. Viret; J.F. Ramee; N. Tubiana-Mathieu; J. Dauba; O. Dupuis; Y. Rinaldi; M. Mabro; N. Aucoin; J. Latreille; F. Bonnetain; C. Louvet; A.K. Larsen; T. Andre; A. de Gramont 2015 |
10.1016/S1470-2045(15)00216-8 |
|
Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors T. Collot; J.D. Fumet; Q. Klopfenstein; J. Vincent; L. Bengrine; F. Ghiringhelli 2018 |
10.21873/anticanres.12943 |
|
Beware of the gorilla: Effect of goal priming on inattentional blindness J.B. Legal; P. Chekroun; V. Coiffard; F. Gabarrot 2017 |
10.1016/j.concog.2017.08.004 |
|
Beyond Biodegradability of Poly(lactic acid): Physical and Chemical Stability in Humid Environments J.R. Rocca-Smith; O. Whyte; C.H. Brachais; D. Champion; F. Piasente; E. Marcuzzo; A. Sensidoni; F. Debeaufort; T. Karbowiak 2017 |
10.1021/acssuschemeng.6b03088 |
|
Beyond dipolar regime in high-order plasmon mode bowtie antennas A. Cuche; S. Viarbitskaya; U. Kumar; J. Sharma; A. Arbouet; C. Girard; E. Dujardin 2017 |
10.1016/j.optcom.2016.11.013 |
|
Beyond GDP: an analysis of the socio-economic diversity of European regions K. Ayouba; J. Le Gallo; A. Vallone 2020 |
10.1080/00036846.2019.1646885, Early Access Date = {AUG 2019 |
|
Beyond GDP: an analysis of the socio-economic diversity of European regions K. Ayouba; J. Le Gallo; A. Vallone 2020 |
10.1080/00036846.2019.1646885 |
|
Beyond longevity: healthy longevity A. Putot; S. Putot; A. Hacquin; P. Manckoundia 2021 |
|
|
Beyond principal component analysis (PCA) of product means: Toward a psychometric view on sensory profiling data B. Dettmar; C. Peltier; P. Schlich 2020 |
10.1111/joss.12555 |
|
Beyond principal component analysis (PCA) of product means: Toward a psychometric view on sensory profiling data B. Dettmar; C. Peltier; P. Schlich 2020 |
10.1111/joss.12555, Early Access Date = {NOV 2019 |
|
Beyond Reperfusion Networks in ST-segment Elevation Myocardial Infarction: Assessment of Quality of Care F. Schiele; J.P. Bassand 2017 |
10.1016/j.rec.2016.09.020 |
|
Beyond traditional approaches: a partial directed coherence with graph theory-based mental load assessment using EEG modality M. Mazher; A. Qayyum; I. Ahmad; M.O. Alassafi Submitted |
10.1007/s00521-020-05408-2, Early Access Date = {OCT 2020 |
|
Beyond traditional approaches: a partial directed coherence with graph theory-based mental load assessment using EEG modality M. Mazher; A. Qayyum; I. Ahmad; M.O. Alassafi Submitted |
10.1007/s00521-020-05408-2 |
|
Beyond Unpredictability: The Importance of Reproducibility in Understanding the Protein Corona of Nanoparticles S. Galmarini; U. Hanusch; M. Giraud; N. Cayla; D. Chiappe; N. von Moos; H. Hofmann; L. Maurizi 2018 |
10.1021/acs.bioconjchem.8b00554 |
|
Beyond `good' and `bad' cyclists. On compensation effects between risk taking, safety equipment and secondary tasks T. Buhler; E. Comby; L. Vaudor; T. von Pape 2021 |
10.1016/j.jth.2021.101131 |
|
BFR ESS: A randomized phase II trial from the GSF/GETO French group evaluating the impact of interruption versus maintenance of aromatase inhibitors in patients with advanced or metastatic low grade endometrial stromal sarcoma after at least 3 years of th I.L. Ray-Coquard; E. Bompas; C. Cropet; M. Donnat; F. Bertucci; L. Chaigneau; S. Metzger; A. Dufresne; C. Guillemet; P. Vassal; L. Venat-Bouvet; H. Vegas; S. Piperno-Neumann; M. Fabbro; J.Y. Blay; P. Dubray-Longeras; A.M. Savoye; M. Brahmi; A. Floquet 2021 |
10.1016/j.annonc.2021.08.1264 |
|
BGM FASt: Besancon Galaxy Model for big data Simultaneous inference of the IMF, SFH, and density in the solar neighbourhood R. Mor; A.C. Robin; F. Figueras; T. Antoja 2018 |
10.1051/0004-6361/201833501 |
|
Bi-allelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome T. Besnard; N. Sloboda; A. Goldenberg; S. Kury; B. Cogne; F. Breheret; E. Trochu; S. Conrad; M. Vincent; W. Deb; X. Balguerie; S. Barbarot; G. Baujat; T. Ben-Omran; A. Bursztejn; V. Carmignac; A.N. Datta; A. Delignieres; L. Faivre; B. Gardie; J. Gueant; P. Kuentz; M. Lenglet; M. Nassogne; V. Ramaekers; R.E. Schnur; Y. Si; E. Torti; J. Thevenon; P. Vabres; L. Maldergem; D. Wand; A. Wiedemann; B. Cariou; R. Redon; A. Lamaziere; S. Bezieau; F. Feillet; B. Isidor 2019 |
|
|
Bi-allelic variants in IPO8 cause a connective tissue disorder associated with cardiovascular defects, skeletal abnormalities, and immune dysregulation A. Ziegler; R. Duclaux-Loras; C. Revenu; F. Charbit-Henrion; B. Begue; K. Duroure; L. Grimaud; A.Laure Guihot; V. Desquiret-Dumas; M. Zarhrate; N. Cagnard; E. Mas; A. Breton; T. Edouard; C. Billon; M. Frank; E. Colin; G. Lenaers; D. Henrion; S. Lyonnet; L. Faivre; Y. Alembik; A. Philippe; B. Moulin; E. Reinstein; S. Tzur; R. Attali; G. McGillivray; S.M. White; L. Gallacher; K. Kutsche; P. Schneeberger; K.M. Girisha; S.S. Nayak; L. Pais; R. Maroofian; A. Rad; B. Vona; E.Ghayoor Karimiani; C. Lekszas; T. Haaf; L. Martin; F. Ruemmele; D. Bonneau; N. Cerf-Bensussan; F. Del Bene; M. Parlato 2021 |
10.1016/j.ajhg.2021.04.020 |
|
Bi-allelic Variants in the GPI Transamidase Subunit PIGK Cause a Neurodevelopmental Syndrome with Hypotonia, Cerebellar Atrophy, and Epilepsy T.Tuyet Mai Nguyen; Y. Murakami; S. Mobilio; M. Niceta; G. Zampino; C. Philippe; S. Moutton; M.S. Zaki; K.N. James; D. Musaev; W. Mu; K. Baranano; J.R. Nance; J.A. Rosenfeld; N. Braverman; A. Ciolfi; F. Millan; R.E. Person; A.L. Bruel; C. Thauvin-Robinet; A. Ververi; C. DeVile; A. Male; S. Efthymiou; R. Maroofian; H. Houlden; S. Maqbool; F. Rahman; ; J. Rousseau; A. St-Denis; M.J. Elrick; I. Anselm; L.H. Rodan; M. Tartaglia; J. Gleeson; T. Kinoshita; P.M. Campeau 2020 |
10.1016/j.ajhg.2020.03.001 |
|
BI-COMDET: Community Detection in Bipartite Networks H. Gmati; A. Mouakher; I. Hilali-Jaghdam 2019 |
10.1016/j.procs.2019.09.186 |